Danish drugmaker Novo Nordisk will spend 5.4 billion Danish kroner, or about $744 million, to expand its clinical manufacturing facilities in a suburb near Copenhagen, Denmark. …
The Food and Drug Administration on Tuesday approved the first gene therapy for a type of hemophilia, giving people with the inherited disorder a treatment …
Generic drugmaker Teva Pharmaceutical on Monday named former Sandoz head Richard Francis as its next CEO, taking over on Jan. 1 from Kåre Schultz, who …
Merck & Co. has agreed to acquire Imago BioSciences, a California-based biotechnology company focused on bone marrow disorders, for more than $1 billion in cash. …
GSK will pull a blood cancer drug from the U.S. market after the treatment failed in a confirmatory clinical trial, the British drugmaker announced Tuesday. …
Just two days after stepping down from his last job, former Rubius Therapeutics head Pablo Cagnoni is again leading a biotech, joining another startup backed …
Dive Brief: A Food and Drug Administration advisory panel on Wednesday backed Ardelyx’s drug for kidney disease patients, lending weight to the company’s appeal of a …
Third quarter earning reports have brought news of layoffs from at least six biotechnology companies this week as a weak market continues to weigh on …
Dive Brief: One year after an initial regulatory rejection, Provention Bio’s injectable drug teplizumab has won Food and Drug Administration approval for preventive treatment of …
GSK will stop selling the drug Zejula for some ovarian cancer patients whose disease is stable after a second line of chemotherapy, the company said …
Dive Brief: Brainstorm Cell Therapeutics said Thursday that the Food and Drug Administration has decided not to review an approval application for a cell therapy …
Biogen on Thursday named former Sanofi executive Christopher Viehbacher to replace Michel Vounatsos as its CEO, ending a six-month search for new leadership and putting …
Cancer drugmaker Seagen on Thursday appointed longtime Novartis executive David Epstein as its new CEO, ending a search that began when the company’s founder, Clay …
An experimental drug from Amgen helped people who are obese lose up to 15% of their body weight in a short study, a finding that …
Growth and Quality scores improved dramatically across all markets, with India the overall biggest winner Frankfurt/Amsterdam, 1st November 2022: Pharma confidence in growth, innovation and …
The CPHI Pharma Awards recognise progress and innovation across the pharma supply chain. This year’s winners are: CEO of the Year – Manni Kantipudi, …
Dive Brief: Four years after going public with a valuation of about $2 billion, Rubius Therapeutics has laid off almost all its employees and is …
Despite safety concerns and pushback from drug regulators, gene therapy continues to be an area of interest to biopharmaceutical dealmakers, as shown by a recent …
Belgian biotechnology company Galapagos plans to eliminate approximately 200 positions as part of a “new strategic direction” that narrows its research activities. Paul Stoffels, the former …
Next month, blood disease specialists and doctors will travel to New Orleans for the 64th annual meeting of the American Society of Hematology, a high-profile …
